Title: Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinase.
Journal: Journal of medicinal chemistry 20050908
1190927-76-4
31040-12-7
108281-78-3
91981-59-8
1471260-44-2
91981-60-1
1005201-24-0 | 1,3,4-Oxadiazole, 2-methyl-5-[3-[4-(methylsulfinyl)phenyl]-5-benzofuranyl]- | AA00025B | MFCD15528930
1006471-43-7 | 1-Ethyl-3-methyl-1H-pyrazole-4-carbonitrile | AA0002HS | MFCD04969707
1007882-58-7 | (S)-tert-Butyl 2-(1h-imidazol-2-yl)pyrrolidine-1-carboxylate | AA0002SQ | MFCD16660093
1009-93-4 | Cyclotrisilazane, 2,2,4,4,6,6-hexamethyl- | AA00032W | MFCD00748135
101-32-6 | 2,2'-(Benzylimino)diethanol | AA0003CQ | MFCD00020587
101084-96-2 | 2-Methoxy-4-nitrobenzonitrile | AA0003NK | MFCD02093781
10128-72-0 | Methyl 3-hydroxyisonicotinate | AA00041W | MFCD00661299
10141-51-2 | Benzenamine, 4-(3-methylbutoxy)-, hydrochloride (9CI) | AA0004CU | MFCD05863938
1015845-89-2 | 2-Methyl-4-(1h-pyrazol-1-yl)benzaldehyde | AA0004S9 | MFCD08059904
10165-86-3 | Methyl 6-formylnicotinate | AA0004YU | MFCD08275010